Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gufic Biosciences Limited ( (IN:GUFICBIO) ) has provided an update.
Gufic Biosciences Limited has disclosed that it received an order from the Office of the Superintendent CGST, Ghaziabad, imposing penalties totaling about Rs 15.64 lakh for alleged excess input tax credit claims and short payment of GST for financial years 2018-19 to 2022-23. The company plans to appeal the order and, based on its assessment and legal advice, does not expect any material impact on its financial operations or other activities, suggesting limited immediate implications for shareholders and business continuity.
More about Gufic Biosciences Limited
Gufic Biosciences Limited is an India-listed pharmaceutical company operating in the biosciences sector, with its shares traded on both BSE and the National Stock Exchange under the symbol GUFICBIO. The company is subject to Indian goods and services tax (GST) regulations and related compliance requirements across its operations.
Average Trading Volume: 2,731
Technical Sentiment Signal: Hold
Current Market Cap: 34.33B INR
Find detailed analytics on GUFICBIO stock on TipRanks’ Stock Analysis page.